-----

Welcome to the September 2013 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, analysis of biopharmaceutical mergers and acquisitions thus far in 2013. Plus analysis of outsourcing trends for contract research and vaccine manufacturing. And the latest developments from the pharmaceutical industry in sustainability and global health.

Global Feature
Amgen’s Acqusition of Onyx Leads Biopharmaceutical Dealmaking in 2013
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Mergers and acquisition activity on both a volume and value basis is up thus far in 2013 comparative to 2012.
>> Read More

Outsourcing
Bioprocessing Advances in Vaccine Manufacture
Eric Langer, president of  BioPlan Associates
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
>> Read More

Outsourcing
CROs Faces Issues with Talent Retention
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
A recent survey shows that talent retention is an issue on an industry level for contract research organizations (CROs), particularly for CROs located outside the United States.
>> Read More

Pharma Industry’s Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
>> Read More

Industry Events

For the full listing of calendar events, see the Calendar of Events page

Pharmaceutical Technology Webcast
Meeting Regulatory and Technical Requirements for Organic Impurity Analysis
Tuesday, September 24, 2013 at 11:00 AM EDT for the US and October 1, 2013 at 15:00 CET for Europe
Gain technical and regulatory insight for organic impurity control and analysis for pharmaceuticals. Learn from leading industry experts on selecting the appropriate analytical methods for detection, analysis, and quantification of organic impurities.
Registration information

Pharmaceutical Technology Webcast
Ensuring Global Regulatory Compliance for Product Registrations: Strategies for Risk Reduction and Operational Efficiency
On-Demand Webcast
Learn from industry and regulatory experts on how to create a robust quality management system for complying with country-based and regional-based regulatory requirements for product registration, product changes, and labeling changes. Gain insight into how to use automation for effectively tracking product registration and related correspondence to ensure global regulatory compliance.
Registration information

Pharmaceutical Technology Webcast
Achieving Raw-Material Transparency in the Pharmaceutical/ Biopharmaceutical Supply Chain
On-Demand Webcast
As regulatory demand increases on biopharmaceutical manufacturers to ensure the quality of the raw materials used for the manufacture of drug substances and formulation of finished drug products, these same demands filter back to suppliers. This 60-minute webcast will examine industry practice and use of regulatory guidance (FDA, EU, and ICH) for developing operational control and quality processes for mitigating risk in the pharmaceutical/biopharmaceutical supply chain. Learn from industry experts how to resolve the challenges toward achieving supply-chain transparency and its management as an ongoing concern.
Registration information

Pharmaceutical Technology Webcast
Risk Mitigation in API Manufacturing in Emerging Markets
On-Demand Webcast
Emerging markets are a crucial part of pharmaceutical companies’ growth strategy.  Pharmaceutical manufacturers must align their strategy with partners that can facilitate access to local markets, manage complex supply chains, meet global and national regulatory standards for quality, and secure production of APIs and intermediates for local as well as established markets in North America and Western Europe. This 60-minute webcast will provide insight and case-study analysis on the approaches taken by pharmaceutical companies to build their manufacturing networks in select emerging markets while mitigating risk in supplier selection and qualification to ensure reliable, consistent API supply.
Registration information